- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03886870
Obesity, Lifestyle and Work Intervention
Does Adding A Work Intervention Into An Already Existing Life Style Intervention Improve Work Ability? A Randomized Controlled Trial Study
Study Overview
Status
Intervention / Treatment
Detailed Description
The background for this study was insights about obesity and sick leave. Obesity is related to lower labor force participation, increased sickness absence and reduced productivity. A Danish study from 2006 reported a yearly 1, 8 million extra days of work absence and close to 1.100 cases of disability pension related to obesity. A 2016-report from OECD show that persons with obesity between the ages 50-59 have three times as much work absence as those who do not struggle with obesity. This indicates that persons with obesity are a group where the need for work rehabilitation is important. Despite this connection, work focus has not been a part of lifestyle interventions for persons with morbid obesity until the last two years.
By introducing a work intervention into a traditional lifestyle rehabilitation program for persons with BMI over 30, the investigators wanted to examine whether this would affect the participants' ability to work and their lifestyle change. The study was designed as a randomized controlled study with an exploring prospective design. The intervention lasted 12 months and each patient had three visits (baseline, 6 and 12 months) at Muritunet, each lasting 4-2-2 weeks. The participants were randomized into two intervention, one with work intervention and one without.
Data material gathered at each stay consisting of self-reported forms, test, journal and individual interviews. These were all collected at baseline, and at six and twelve months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants with a Body Mass Index (BMI) > 30 with or without comorbidity
Exclusion Criteria:
- People without a capacity to consent.
- People with severe alcohol and/or drug abuse.
- People with a major mental illness.
- Being pregnant.
- People with a health condition that contraindicates physical activity.
- People with or plan to apply for disability benefits.
- People with permanently adapted work.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lifestyle and work intervention
Lifestyle intervention with work focus.
|
The intervention period lasted for a year with three institution-based stay, 4 weeks at baseline and 2 weeks at 6 and 12 months. At baseline, participants got a functional assessment and an individual adjusted rehabilitation plan. At all three stages: The intervention contains activity training with focus on joy of movement, strength- and cardio-training. There was lectures and cognitive therapy to promote self-care and lifestyle change. The intervention contained lectures on diet, nutrition and cooking-classes. Participants set goals at baseline and adjusting these during the progress. They developed exercise programs designed to use at home. |
Experimental: Lifestyle intervention
Lifestyle intervention without work focus.
|
The intervention period lasted for a year with three institution-based stays, 4 weeks at baseline and 2 weeks at 6 and 12 months.
At baseline, participants got a functional assessment and an individual adjusted rehabilitation plan.
At all three stages: The intervention contains activity training with a focus on the joy of movement, strength- and cardio-training.
There were lectures and cognitive therapy to promote self-care and lifestyle change.
The intervention contained lectures on diet, nutrition and cooking-classes.
Participants set goals at baseline and adjusting these during the progress.
Exercise programs was designed to use at home.
The Cognitive Information Processing model of career guidance was the mainframe for the work dimension.
All participants had talks with the work consultant at baseline, 6 and 12 months.
Two work lectures, "Duties and rights as employees" and "Work as medicine".
When needed the work consultant contacted the employer in order to facilitate changes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Full or partial return to work.
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Mapping changes in work employability and work related factors with survey data from the ARR form (http://www.arbeidoghelse.no).
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight loss (kilograms)
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Measured changes with Tanita MC-780U Multi Frequency Segmental Body Composition Analyzer.
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Return to work self-efficacy
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Mapping changes with the Return-to-work-efficacy scale (RTWSE-19).
The 19-item RTWSE-19 scale is a new self-report measure intended to assess workers' beliefs of their current ability to resume normal job responsibilities following pain onset.
Response range (1-10). 1 is "not sure at all" and 10 is "very sure".
The 19 subscales are divided into three main categories, and the total score is the sum of these catagories.
Higher value indicate better outcome.
(Shaw et.al 2011).
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Quality of Life (15D), health-related quality of life
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Mapping changes in 15D.
The 15D is a generic, comprehensive (15-dimensional), self-administered instrument for measuring HRQoL.
5 ordinal levels on each dimension, by which more or less of the attribute is distinguished.
A set of utility or preference weights is used to generate the 15D score (single index number) on a 0-1 scale.
The valuation system of the 15D is based on an application of the multiattribute utility theory.
The single index (15D score) on a 0 1 scale, representing the overall HRQoL (0 = being dead, 0.0162 = being unconscious or comatose, 1 = no problems on any dimension = 'full' HRQOL) is calculated from the health state descriptive system by using a set of population based preference or utility weights.
(Harri Sintonen, http://www.15d-instrument.net).
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Subjective somatic and psychological complaints
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Mapping changes with the scoring system subjective health complaints (SHC).
The SHC consists of 29 questions concerning severity and duration of subjective somatic and psychological complaints.
Intensity of each complaint is scored on a four-point scale from 0-3, where 0 is no complaints and three is severe complaints.
The SHC inventory yields scores on single items and a total number of health complaints categorized into five factors: musculoskeletal pain (alpha=0.74),
pseudoneurology (alpha=0.73),
gastrointestinal problems (alpha=0.62),
allergy (alpha=0.58)
and flu (alpha=0.67).
Eriksen HR, Ihlebæk C, Ursin H.
A scoring system for subjective Health complaints (SHC).
Scand J Public Health.
1999;27:63-72.
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Vo2 peak
Time Frame: Data collected during the interventions, baseline and 12 months.
|
Measured changes in the maximum amount of oxygen the participant can utilize during intense exercise.
Measured in litres of oxygen per minute (L/min) or as a relative rate in (for example) millilitres of oxygen per kilogram of body mass per minute (e.g., mL/(kg·min).
Physical test on a treadmill.
|
Data collected during the interventions, baseline and 12 months.
|
Body Mass Index
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Height will be added in Tanita MC-780U Multi Frequency Segmental Body Composition Analyzer.
BMI will be reported in kg/m².
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Waist circumstance (cm).
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Measured changes with Tanita MC-780U Multi Frequency Segmental Body Composition Analyzer.
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Hight (centimetmeters)
Time Frame: Data collected during the interventions, baseline.
|
The distance from the bottom of the feet to the top of the head, standing erect, measured with a stadiometer, in centimetres.
|
Data collected during the interventions, baseline.
|
Promoting and hindering factors for Return to work.
Time Frame: Data collected during the interventions, baseline, 6 and 12 months.
|
Mapping contextual conditions and mechanisms that might be important in the process back to work through In-Depth interviews
|
Data collected during the interventions, baseline, 6 and 12 months.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Geir Ove Vegsund, Muritunet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/697 REK South-East
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Lifestyle intervention
-
Sheba Medical CenterD-Cure, Israel; Chief Scientist, The Israel Ministry of ScienceCompleted
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Michael... and other collaboratorsActive, not recruiting
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHyperglycemia | Glucose Metabolism Disorders | Metabolic Diseases | Obesity | Diabetes Mellitus | Endocrine System Diseases | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Signs and SymptomsUnited States
-
Laval UniversityActive, not recruitingPhysical Activity | Weight Loss | Dietary Modification | BreastfeedingCanada
-
University of AdelaideCompletedInsulin Resistance | Type 2 DiabetesAustralia
-
Umeå UniversityActive, not recruitingHypertension,Essential | Lifestyle-related ConditionSweden
-
Mayo ClinicCompletedObesityUnited States
-
DongGuk UniversityNational Research Foundation of KoreaUnknown
-
Beth Israel Deaconess Medical CenterCenter for Nutritional Research Charitable TrustCompletedObesity | Weight GainUnited States
-
Centro de Investigacion SanitariaUniversity of Helsinki; International Diabetes FederationCompletedGlucose Metabolism Disorders | Type 2 DiabetesColombia